← Back to Search

A Faithful Response to COVID-19 for COVID-19 Testing (FR Trial)

N/A
Waitlist Available
Led By Jannette Berkley-Patton, PhD
Research Sponsored by University of Missouri, Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants will be eligible to participate if they are: a) self-identified as African American/Black; b) aged 18 or older; c) willing to participate in 2 surveys after church services, electronically, by phone, or in the study's office space; d) willing to provide contact information (i.e., two phone numbers, mailing/email address, phone numbers for two persons with whom they have ongoing contact; and e) regularly attend church (>once a month) or use church outreach services (e.g., daycare services, food programs) > 4 times/year.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 6 months
Awards & highlights

FR Trial Summary

This trial will test a multilevel intervention (COVID-19 testing and linkage to care) against a control condition (nontailored, attention-control) on uptake of COVID-19 testing with adult African American church-affiliated members at 6 months. Contact tracing approval and COVID19 prevention behaviors will also be examined.

Eligible Conditions
  • COVID-19 Testing
  • COVID-19 Testing Control Condition

FR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

FR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COVID-19 testing uptake
Secondary outcome measures
COVID-19 prevention behaviors
Linkage to care

FR Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multilevel, religiously-culturally tailored COVID-19 testing and linkage to careExperimental Treatment1 Intervention
Church-based COVID19 promoted with a religiously-culturally tailored Faithful Response COVID19 Toolkit delivered by church health workers (trained in an enhanced communication style) through multilevel church outlets (e.g., sermon guide, responsive reading, church bulletin inserts, automated text messages) and linkage to care delivered by community health workers who also conduct contact tracing; inclusive of 2 church-based COVID-19 testing events at each participating site.
Group II: Standard COVID19 information (non-tailored) attention control armActive Control1 Intervention
Standard COVID-19 information that has not been tailored delivered by trained church health workers via a toolkit; inclusive of 2 church-based COVID19 testing evens at each participating site.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
A Faithful Response to COVID-19
2021
N/A
~1020

Find a Location

Who is running the clinical trial?

University of Missouri, Kansas CityLead Sponsor
68 Previous Clinical Trials
31,591 Total Patients Enrolled
Jannette Berkley-Patton, PhDPrincipal Investigator - UMKC School of Medicine
University of Missouri, Kansas City

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people with the relevant medical condition able to participate in this trial at this time?

"That is correct. The listing on clinicaltrials.gov affirms that the 960 participants needed for this study are currently being recruited from 9 different locations. The trial was first posted on June 6th, 2021 and was last updated on July 22nd, 2021."

Answered by AI

How many patients are allowed to be a part of this experiment?

"That is correct, the online information from clinicaltrials.gov suggests that this study is open for recruitment. This trial was first advertised on June 6th, 2021 and has since been updated on July 22nd. A total of 960 people are needed from 9 different locations."

Answered by AI

Who else is applying?

What state do they live in?
Missouri
How old are they?
18 - 65
What site did they apply to?
Memorial Church International
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Faithful Response to COVID-19 Project
Jannette Berkley-Patton 2021. "A Faithful Response to COVID-19 Project". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04978207.
~264 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top